Health Care & Life Sciences » Pharmaceuticals | Cathay International Holdings Ltd.

Cathay International Holdings Ltd. | Income Statement

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
73,467.10
91,113.10
79,124.00
87,751.40
89,560.50
63,217.90
Cost of Goods Sold (COGS) incl. D&A
37,366.90
48,212.70
46,589.10
45,320.50
48,418.20
40,416.80
Gross Income
36,100.20
42,900.40
32,534.90
42,430.90
41,142.30
22,801
SG&A Expense
33,558.40
35,265.10
33,713.80
42,264.90
42,741.20
32,938.20
EBIT
2,541.80
7,635.30
1,178.80
1,163.60
1,598.80
11,027.40
Unusual Expense
739.60
21.90
5,588.40
2,267.10
4,575.20
2,127.60
Non Operating Income/Expense
2,230.20
1,515.30
3,104.50
389.80
13,782.20
7,054.90
Interest Expense
3,354.20
4,722.60
5,471.90
6,321.10
7,848.90
7,799.60
Pretax Income
1,037.00
4,820.40
8,222.90
6,588.60
271.80
13,541.30
Income Tax
2,374.80
2,767.60
1,457.60
2,270.10
1,106.50
1,442.20
Equity in Affiliates
1,017.20
1,309.40
1,415.10
1,274.70
1,344.10
1,262.90
Consolidated Net Income
320.50
3,362.20
8,265.50
7,583.90
509.40
13,720.50
Net Income
3,960.70
787.70
8,900.40
8,757.10
5,374.20
13,946.30
Net Income After Extraordinaries
3,960.70
787.70
8,900.40
8,757.10
5,374.20
13,946.30
Net Income Available to Common
3,960.70
787.70
8,900.40
8,757.10
5,374.20
13,946.30
EPS (Basic)
0.01
0.00
0.02
0.02
0.01
0.04
Basic Shares Outstanding
378,043.00
378,043.00
377,979.00
377,958.00
377,958.00
377,959
EPS (Diluted)
0.01
0.00
0.02
0.02
0.01
0.04
Diluted Shares Outstanding
378,043.00
378,043.00
377,979.00
377,958.00
377,958.00
377,959
EBITDA
4,956.80
11,954.00
3,745.20
6,910.20
4,325.90
5,215.20
Other Operating Expense
-
-
-
997.60
-
890.20
Non-Operating Interest Income
358.90
414.20
911.80
446.20
512.50
358.50
Minority Interest Expense
3,640.20
4,149.90
634.90
1,173.20
5,883.60
225.70

About Cathay International Holdings

View Profile
Address
Suites 1203-4, 12/F
Hong Kong
Hong Kong
Employees -
Website http://www.cathay-intl.com.hk
Updated 07/08/2019
Cathay International Holdings Ltd. engages in investment activities with interests in the healthcare business and hotel operations. It operates through the following segments: Lansen, Haizi, Natural Dailyhealth, Botai, and Hotel. The Lansen segment focuses on the manufacture, marketing, and sale of specialty pharmaceuticals, plant extracts, healthcare products, and other pharmaceuticals in China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.